TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCEMaël Heiblig, Xavier Thomas, Franck E. Nicolini et al.|Mediterranean Journal of Hematology and Infectious Diseases|2015Cited by 23
A076 Long-Term Follow-up of Multiple Myeloma Patients Treated by VELCADEMarie‐Cécile Michallet, Jacques Troncy, Mohamed Sobh et al.|Clinical Lymphoma & Myeloma|2009Cited by 0
Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patientsMauricette Michallet, Sandrine Hayette, Mohamad Sobh et al.|Blood|2008Cited by 0
Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade®): A Study on Efficacy, Tolerance, Survival and Time to ProgressionMauricette Michallet, Jacques Troncy, Giovanna Cannas et al.|Blood|2008Cited by 0